Company intelligence / Profile preview

Hyperion DeFi

New York, New York, United Stateseyenovia.com ↗
Ownership
Public · HYPD
Employees
~13
Development stage
Other
01

Overview

Hyperion DeFi is pivoting from ophthalmic device and drug development (notably the Optejet delivery system and drug/device combinations) to a novel public company model centered on holding and staking digital assets (HYPE token). Its lead device, Optejet, is aiming for FDA registration in September 2025. Main therapeutic products (e.g., Mydcombi, clobetasol propionate ophthalmic suspension) have US regulatory clearances for targeted indications, and new formulation co-development is ongoing.

Therapeutic areas
Ophthalmology
Modalities
Small moleculeBiologicDevice
Industry
Biotech
02

Drug pipeline

4 assets

atropine

Approved

3 more assets in the full pipeline.

Request access →
03

Partnerships

Bausch Health Ireland LimitedArctic Vision (Hong Kong)Senju PharmaceuticalFormosa PharmaceuticalsKinetiq (for DeFi validator partnership)
04

Financials

Market cap
$54.3M
Total revenue
$357.7K
Enterprise value
$53.5M

Beyond the preview

Go deeper on Hyperion DeFi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyperion DeFi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call